TGFBI antibody [C1C3]
GTX100744
ApplicationsWestern Blot
Product group Antibodies
TargetTGFBI
Overview
- SupplierGeneTex
- Product NameTGFBI antibody [C1C3]
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID7045
- Target nameTGFBI
- Target descriptiontransforming growth factor beta induced
- Target synonymsBIGH3, CDB1, CDG2, CDGG1, CSD, CSD1, CSD2, CSD3, EBMD, LCD1, transforming growth factor-beta-induced protein ig-h3, RGD-CAP, RGD-containing collagen-associated protein, beta ig-h3, betaig-h3, kerato-epithelin, transforming growth factor beta-induced 68kDa, transforming growth factor, beta-induced, 68kD
- HostRabbit
- IsotypeIgG
- Protein IDQ15582
- Protein NameTransforming growth factor-beta-induced protein ig-h3
- Scientific DescriptionThis gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Lin TY, Yang CH, Chou HC, et al. EGFR Mutation-Harboring Lung Cancer Cells Produce CLEC11A with Endothelial Trophic and Tumor-Promoting Activities. Cancers (Basel). 2022,14(5). doi: 10.3390/cancers14051356Read this paper
- Brzozowski JS, Bond DR, Jankowski H, et al. Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion. Sci Rep. 2018,8(1):8822. doi: 10.1038/s41598-018-27180-zRead this paper
- Kosla J, Dvorakova M, Dvorak M, et al. Effective myofibroblast dedifferentiation by concomitant inhibition of TGF-β signaling and perturbation of MAPK signaling. Eur J Cell Biol. 2013,92(12):363-73. doi: 10.1016/j.ejcb.2013.10.013Read this paper
- Kosla J, Dvorak M, Cermak V. Molecular analysis of the TGF-beta controlled gene expression program in chicken embryo dermal myofibroblasts. Gene. 2013,513(1):90-100. doi: 10.1016/j.gene.2012.10.069Read this paper







